DeepCure

Reimagining small molecule therapies for immune diseases

Boston, United States · $64.6M raised

Business Model
B2B
Total Funding
$64.6M
Last Round
$24.6M Series AApr 2024
Rounds
2

About

DeepCure's proprietary PocketExpander technology uses AI and physics-based methods, including quantum mechanical and molecular dynamics simulations, to identify physical and chemical features on protein surfaces that can interact with small molecules — enabling it to pursue targets with no known ligand and design molecular glues. Its MolGen molecular generation tool uses deep reinforcement learning to build readily synthesizable compound libraries meeting ADME-Tox and target candidate profile requirements. DiscoveryHub, its collaboration platform, lets structural biologists, computational chemists, AI engineers, medicinal chemists and biologists share data across the design-make-test-analyze cycle.

Summary

DeepCure is an Artificial Intelligence company based in Boston, United States. It has raised $64.6M in total across 2 rounds, most recently a $24.6M Series A round in Apr 2024.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries AApr 2024
$24.6M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Similar Companies